Search results
Plus (PSTV) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Zacks via Yahoo Finance· 9 months agoAfter losing some value lately, a hammer chart pattern has been formed for Plus (PSTV), indicating...
Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 1 year agoPlus (PSTV) delivered earnings and revenue surprises of -6.67% and 88.75%, respectively, for the...
Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 months agoPlus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript March 5, 2024 Plus...
Plus Therapeutics Full Year 2023 Earnings: Beats Expectations
Simply Wall St. via Yahoo Finance· 2 months agoPlus Therapeutics (NASDAQ:PSTV) Full Year 2023 Results Key Financial Results Revenue: US$4.91m (up...
Plus Therapeutics Shares Surge On Positive Data From Lead Brain Cancer Candidate
Benzinga via Yahoo Finance· 2 years agoPlus Therapeutics Inc (NASDAQ: PSTV) presented data from two ongoing trials of its lead...
Why Are Plus Therapeutics Shares Gaining Today?
Benzinga via Yahoo Finance· 2 years agoPlus Therapeutics Inc (NASDAQ: PSTV) has finalized and signed a grant contract with the Cancer Prevention & Research Institute of Texas (CPRIT) for its...
EXCLUSIVE: Plus Therapeutics Lead Candidate Shows Preliminary Safety, Efficacy In Type Of Brain...
Benzinga via Yahoo Finance· 9 months agoPlus Therapeutics Inc (NASDAQ: PSTV) reported data from the ReSPECT-LM study evaluating the...
Plus Therapeutics Highlights Updates On Lead Program In Brain Cancer Indications
Benzinga via Yahoo Finance· 1 year agoPlus Therapeutics Inc (NASDAQ: PSTV) presented data from two ongoing trials evaluating its lead...
Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
Benzinga via Yahoo Finance· 4 weeks agoPlus Therapeutics Inc (NASDAQ:PSTV) has been selected for $3 million in funding recommendation by...
EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System...
Benzinga via Yahoo Finance· 8 months agoPlus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ:...
